Covid-19 Coronavirus

Information for adults

Autumn Booster Programme

COVID-19 vaccination: Guide to Autumn Booster (75+ years and at risk)
18 August 2022

A guide to Booster Vaccination - 18 and over and 16 and over who are at risk

A guide to booster vaccination for individuals aged 18 years and over and those aged 16 years and over who are at risk
2 December 2021

What to expect after your vaccination

COVID-19 vaccination: what to expect after vaccination
9 November 2021

Living abroad

COVID-19 vaccines if you live abroad (
30 June 2021

British Sign Language (BSL)

British Sign Language (BSL) videos are also available
COVID-19 vaccination: British Sign Language resources ( 
9 November 2021

NHS England Learning Disability and Autism videos

NHS England Learning Disability and Autism Programme have produced an information about vaccines video for people with a learning disability and their carers.

A set of short social media clips of the video are available to download from the Health Publications website.

Consent forms

Consent form for all doses (excluding AstraZeneca) for 18 years and over 

mRNA COVID-19 Vaccine Consent Form
5 September 2022

Best Interest, Residential, Relative and Clinician Opinion forms are also available on request.

Vaccination Cards are supplied with each dose of vaccine.

These will be given to the recipient with information about their vaccine: the date given and the date of appointment for their second or future doses.

Vaccination Appointments

Walk in sessions are now available. Appointments cannot be booked for these sessions. Please see the walk in session schedule for dates and times.

If you are aged between 5 and 18 years and are clinically vulnerable, or housebound and unable to travel, please call 111 to book your appointment.

Digital vaccine record

Download your vaccination status via the NHS App
Mobile Phone App: UK NHS COVID Pass for use by Isle of Man residents.

Authorised vaccines and patient information leaflet (PIL)

Vaccine Product Information

This information is a copy of the product information for COVID-19 vaccines, which outlines the conditions under which the vaccine should be used and information on its known safety.

This information may be updated, if necessary.

The MHRA is unable to offer medical advice and so if a patient has any questions about a vaccine they should contact their doctor or pharmacist. Suspected adverse reactions to a vaccine can be Yellow Card.

The Information for UK and IOM recipients document provides information for patients.

Spikevax vaccine

Spikevax Original

Last updated 12/22 - Patient Information Leaflet for Spikevax

Updated 14 December 2022

Spikevax Original/Bivalent BA.1

(50 micrograms/50 micrograms)/mL dispersion for injection


Updated December 2022

Comirnaty original/Bivalent BA.1

Comirnaty original/Bivalent BA.1  (15/15 micrograms)/dose dispersion for injection

Adults and adolescents from 12 years

COVID-19 mRNA Vaccine (nucleoside modified)

Comirnaty 30 Concentrate

Last updated 11/2022 - Patient Information Leaflet Comirnaty 30 micrograms/dose concentrate for age 12+ (purple cap)

Updated 6 January 2023

Comirnaty 10 Concentrate micrograms/dose concentrate for dispersion for injection

Children 5 to 11 years

COVID-19 mRNA Vaccine (nucleoside modified)



Last updated 11/2022 - Product Information Leaflet (PIL) for Nuvaxovid dispersion for injection

Updated 9 November 2022

Side Effects

Blood clotting, myocarditis and pericarditis, and Guillain-Barré Syndrome (GBS)

See COVID-19 vaccination and rare side effects ( for information and guidance on these very rare conditions reported after COVID-19 vaccination.

9 January 2023

Pregnant women who are inadvertently immunised should be notified to the Vaccine in Pregnancy surveillance programme (

25 August 2022

Reporting side effects

You can report any suspected side effects of vaccines and medicines through the Yellow Card scheme by calling 0800 731 6789; or registering and downloading the Yellow Card app; or online.

MHRA regular reports

The MHRA Weekly report covering adverse reactions to approved COVID-19 vaccines are published regularly.


Local Vaccination delivery: COVID-19 vaccine statistics (Respiratory Surveillance -  includes surveillance for respiratory illness symptoms, sentinel swabbing, vaccination and mortality.
Updated weekly

Guidance: COVID-19 vaccination in pregnancy surveillance
25 November 2021

Guidance: Monitoring reports of the effectiveness of COVID-19 vaccination
1 September 2022

Research and analysis: COVID-19 vaccine weekly surveillance reports (

As the COVID-19 programme continues to change please check items regularly for any updates or changes.

Public Health Isle of Man has adapted the information supplied by JCVI and PHE for the delivery of the COVID-19 Vaccination programme and this has been sourced from COVID-19 vaccination programme (

To view older leaflets and information, please visit the COVID-19 vaccination archive.

Updated 23 January 2023

Back to top